PTK2B and myeloproliferative neoplasm: In addition, Cbl Y368C has also been identified in MDS/MPN clinical samples, and, like Cbl Y371C and Y371S, has been shown to potentiate transformation in cells and in mice; however, whether PTK ubiquitination is compromised remains unknown [19].